These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 20529135

  • 21. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A, Wyndaele JJ, Sieber P.
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients.
    Michel MC, Oelke M, Goepel M, Beck E, Burkart M.
    Neurourol Urodyn; 2007 Mar; 26(2):190-5. PubMed ID: 17096320
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
    Kerdraon J, Robain G, Jeandel C, Mongiat Artus P, Gamé X, Fatton B, Scheiber-Nogueira MC, Vetel JM, Mares P, Petit AC, Amarenco G, Groupe de recherche appliquée à la pelvi-périnéologie de la personne âgée (GRAPPPA).
    Prog Urol; 2014 Sep; 24(11):672-81. PubMed ID: 25214448
    [Abstract] [Full Text] [Related]

  • 26. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG, Bachmann G, Scarpero H, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T.
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antimuscarinics for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivity.
    Glavind K, Chancellor M.
    Int Urogynecol J; 2011 Aug; 22(8):907-17. PubMed ID: 21468739
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.
    Wagg A, Oelke M, Angulo JC, Scholfield D, Arumi D.
    Drugs Aging; 2015 Feb; 32(2):103-25. PubMed ID: 25673122
    [Abstract] [Full Text] [Related]

  • 33. Health-related consequences of overactive bladder.
    Wagner TH, Hu TW, Bentkover J, LeBlanc K, Stewart W, Corey R, Zhou Z, Hunt T.
    Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
    Liu HT, Chancellor MB, Kuo HC.
    BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
    Cardozo L, Hessdörfer E, Milani R, Arañó P, Dewilde L, Slack M, Drogendijk T, Wright M, Bolodeoku J, SUNRISE Study Group.
    BJU Int; 2008 Nov; 102(9):1120-7. PubMed ID: 18990175
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S.
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [Abstract] [Full Text] [Related]

  • 40. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    Chapple CR, Van Kerrebroeck PE, Jünemann KP, Wang JT, Brodsky M.
    BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.